Interim report January – June 2023 for CombiGene AB (publ)
August 25, 2023
April – June 2023• Net sales: TSEK 1,788 (4,738).• Other operating revenues: TSEK 1,413 (9,800).• Profit
April – June 2023• Net sales: TSEK 1,788 (4,738).• Other operating revenues: TSEK 1,413 (9,800).• Profit
January – March 2023• Net sales: TSEK 2,168 (11,403).• Other operating revenues: TSEK 0 (2,801).• Profit
October – December 2022• Net sales: TSEK 5,346 (84,042).• Other operating revenues: TSEK 674 (1,098).• Profit
October – December 2022• Net sales: TSEK 5,346 (84,042).• Other operating revenues: TSEK 674 (1,098).• Profit
July – September 2022• Net sales: 5,213 (0) TSEK.• Other operating revenues: 8,313 (423) TSEK.• Profit
April – June 2022• Net sales: 4,738 (0) TSEK.• Other operating revenues: 9,865 (839) TSEK.• Profit
Period January – March 2022• Net sales: 11,403 (0) TSEK.• Other operating revenues: 3,102 (5,118) TSEK.• Profit
Period October – December 2021• Net sales: 84,042 (0) TSEK.• Other operating revenues: 1,098 (3,171) TSEK.•
Period July – September 2021• Net sales: 0 (0) TSEK.• Other operating revenues: 423 (2,673) TSEK.•
Second quarter April – June 2021• Net sales: 0 (0) TSEK.• Other operating income: 839 (2161)